Association Between Telomere Length and Cardiovascular Risk: Pharmacological Treatments Affecting Telomeres and Telomerase Activity.
Telomeres
cardiovascular disease
inflammation
pharmacological treatments
telomerase activity
telomere length
Journal
Current vascular pharmacology
ISSN: 1875-6212
Titre abrégé: Curr Vasc Pharmacol
Pays: United Arab Emirates
ID NLM: 101157208
Informations de publication
Date de publication:
2022
2022
Historique:
received:
18
02
2022
revised:
03
06
2022
accepted:
06
06
2022
pubmed:
21
8
2022
medline:
20
12
2022
entrez:
20
8
2022
Statut:
ppublish
Résumé
Telomeres represent the ends of chromosomes, and they are composed of an extensive number of - TTAGGG nucleotide sequence repeats in humans. Telomeres prevent chromosome degradation, participate in stabilization, and regulate the DNA repair system. Inflammation and oxidative stress have been identified as important processes causing cardiovascular disease and accelerating telomere shortening rate. This review investigates the link between telomere length and pathological vascular conditions from experimental and human studies. Also, we discuss pharmacological treatments affecting telomeres and telomerase activity.
Identifiants
pubmed: 35986545
pii: CVP-EPUB-125665
doi: 10.2174/1570161120666220819164240
doi:
Substances chimiques
Telomerase
EC 2.7.7.49
Types de publication
Review
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
465-474Informations de copyright
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.